Localized provoked vulvodynia (LPV) is a chronic condition impacting more than one in ten women at some point in their lives. It results in severe vulvar pain and often leads to additional health issues, such as depression, anxiety and fertility problems. Given the prevalent nature of the condition and lack of adequate treatment available on the market, we embraced the challenge of utilizing the unique properties of maresins to aid in the resolution of vulvodynia inflammation.

With robust preclinical science demonstrating the role of maresins in relieving vulvodynia-related pain and inflammation, we are now in the process of conducting clinical trials to develop an efficacious and highly-targeted maresin-based treatment for LPV.